Skip to main content
Log in

Inhibition by the PAF antagonist WEB 2086 of PAF induced inositol-1,4,5-trisphosphate production in human platelets

  • PAF and Signal Transduction
  • Published:
Lipids

Abstract

Platelet-activating factor (PAF) activates human platelets by binding to a putative PAF receptor which evokes the rapid formation of inositol-1,4,5-trisphosphate (IP3) by phospholipase C mediated phosphatidylinositol-4,5-bisphosphate (PIP2) hydrolysis. Stimulation of [3H]inositol-labeled human platelets by PAF (1 nM-1μM) resulted in a concentration-dependent increase of intracellular IP3, IP2 and inositolmonophosphate (IP1). IP1 levels increased up to three-fold upon maximum stimulation by 100 nM PAF. The EC50 concentration for PAF was 1.2±0.3 nM. Addition of the hetrazepinoic PAF antagonist, WEB 2086, inhibited PAF stimulated hydrolysis of PIP2 in a dose-dependent manner. WEB 2086 (100 μM) blocked inositol-1,4,5-trisphosphate formation down to baseline levels (IC50=33±12 μM WEB 2086). In thrombin and ADP stimulated platelets, inositol phosphate (IP) generation was not influenced by WEB 2086. It is concluded that WEB 2086 selectively antagonizes PAF-induced increases in IP and does not interfere directly with intracellular signal transduction. Instead, WEB 2086, which has been shown to bind specifically and with high affinity (Ki 15 nM) to human platelets, acts as a competitive antagonist at the PAF receptor level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ADP:

adenosine diphosphate

DAG:

diacylglycerol

IP3 :

inositol-1,4,5-trisphosphate

IP:

inositol phosphates

PAF:

platelet-activating factor, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine

PIP2 :

phosphatidylinositol-4,5-bisphosphate

PKC:

protein kinase C

PLC:

phospholipase C

References

  1. Braquet, P., Touqui, L., Shen, T.Y., and Vargaftig, B.B. (1987)Pharmacol. Rev. 39, 97–145.

    PubMed  CAS  Google Scholar 

  2. Valone, F.H., Coles, E., Reinhold, V.R., and Goetzl, E.J. (1982)J. Immunol. 129, 1637–1641.

    PubMed  CAS  Google Scholar 

  3. Williams, K.A., and Haslam, R.J. (1984)Biochim. Biophys. Acta 770, 216–223.

    Article  PubMed  CAS  Google Scholar 

  4. Houslay, M.D., Bojanic, D., and Wilson, A. (1986)Biochem. J. 234, 737–740.

    PubMed  CAS  Google Scholar 

  5. Shukla, S.D., and Hanahan, D.J. (1983)Arch. Biochem. Biophys. 224, 626–629.

    Article  Google Scholar 

  6. O'Rourke, F.A., Halenda, S.P., Zavoico, G.B., and Feinstein, M.B. (1985)J. Biol. Chem. 260, 956–962.

    PubMed  Google Scholar 

  7. Vargaftig, B.B., Chignard, M., and Benveniste, J. (1981)Biochem. Pharmacol. 30, 263–271.

    Article  PubMed  CAS  Google Scholar 

  8. Siess, W., Weber, P.C., and Lapetina, E.G. (1984)J. Biol. Chem. 259, 8286–8292.

    PubMed  CAS  Google Scholar 

  9. Shukla, S.D., Franklin, C.C., and Carter, M.G. (1987)Biochim. Biophys. Acta 929, 134–141.

    Article  PubMed  CAS  Google Scholar 

  10. Huang, E.M., and Detriller, T.C. (1986) inBiochemistry of Platelets (Phillipps, D.R., and Shulman, M.A., eds.), pp. 1–68. Academic Press, New York.

    Google Scholar 

  11. Casals-Stenzel, J., Muacevic, G., and Weber, K.H. (1987)J. Pharmac. Exp. Ther. 241, 947–981.

    Google Scholar 

  12. Heuer, H., Birke, F.W., Casals-Stenzel, J., and Weber, K.H. (1989)Prostaglandins 35, 838 (Abstract).

    Article  Google Scholar 

  13. Birke, F.W., and Weber, K.H. (1988)Clin. Exp. Pharmacol. Physiol. Suppl. 13, 2 (Abstract).

    Google Scholar 

  14. Ukena, D., Dent, G., Birke, F.W., Robaut, C., Sybrecht, G.W., and Barnes, P. (1988)FEBS LETT. 228, 285–289.

    Article  PubMed  CAS  Google Scholar 

  15. Dent, G., Ukena, D., Chanez, P., Sybrecht, G., and Barnes, P. (1989)FEBS LETT. 244, 365–368.

    Article  PubMed  CAS  Google Scholar 

  16. Ukena, D., Kroegel, C., Kent, G., Jukawa, T., Sybrecht, G., and Barnes, P. (1989)Biochem. Pharmacol. 38, 1702–1705.

    Article  PubMed  CAS  Google Scholar 

  17. Berridge, M.J., Dawson, R.M.C., Downes, C.S., Heslop, G.P., and Irvine, R.F. (1983)Biochem. J. 212, 473–482.

    PubMed  CAS  Google Scholar 

  18. Rominger, K.L., and Albert, H.J. (1985)Drug Research 35, 415–420.

    PubMed  CAS  Google Scholar 

  19. Abdel-Latif, A.A. (1986)Pharmacol. Rev. 38, 227–272.

    PubMed  CAS  Google Scholar 

  20. Shukla, S.D., Morrison, W.J., and Dhar, A. (1989)Molec. Pharmacol. 35, 409–413.

    CAS  Google Scholar 

  21. Shukla, S.D. (1985)Arch. Biochem. Biophys. 240, 674–681.

    Article  PubMed  CAS  Google Scholar 

  22. Simon, M.F., Chap, H., Braquet, P., and Douste-Blazy, L. (1989)Thromb. Res. 45, 299–309.

    Article  Google Scholar 

  23. Nishizuka, Y. (1984)Nature 308, 693–698.

    Article  PubMed  CAS  Google Scholar 

  24. Uhing, R.J., Prpic, V., Hollenbach, P.W., and Adams, D.O. (1989)J. Biol. Chem. 264, 9224–9230.

    PubMed  CAS  Google Scholar 

  25. Barzaghi, G., Saran, H.M., and Mong, S. (1989)J. Pharmacol. Exp. Ther. 248, 559–566.

    PubMed  CAS  Google Scholar 

  26. Block, L.H., Imhof, E., and Perrucheud, A.P. (1988)Am. Rev. Respir. Dis. 137, 235.

    Google Scholar 

  27. Pretolani, M., Ferrer-Lopez, P., and Vargaftig, B.B. (1989)Biochem. Pharmacol. 28, 1373–1384.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Birke, F.W., Ensinger, H.A. Inhibition by the PAF antagonist WEB 2086 of PAF induced inositol-1,4,5-trisphosphate production in human platelets. Lipids 26, 1050–1053 (1991). https://doi.org/10.1007/BF02536500

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02536500

Keywords

Navigation